title: Physical health and schizophrenia.
abstract: OBJECTIVE
  Patients with schizophrenia have higher than expected rates of morbidity and mortality. It is debatable whether this is related to shared risk factors, antipsychotic medication or inherent to the condition itself. This review will describe this association and the recent advances in the field.
  
  
  RESULTS
  The majority of patients with schizophrenia have at least one chronic comorbid medical condition. In the absence of systematic screening this may or may not be brought to the attention of health professionals. The cause of high rates of physical illness appears to be multifactorial involving shared vulnerability and genetic factors. Yet it is vascular risk factors and the adverse effects of prescribed medication that are most amenable to intervention. Current atypical antipsychotics may offer neurological and cognitive benefits, but there is accumulating evidence of problems with weight gain, diabetes, lipid dysregulation, metabolic syndrome and sexual side effects.
  
  
  CONCLUSIONS
  The physical health of patients with schizophrenia remains a concern. Yet the quality of medical and psychiatric care of patients with comorbid physical and mental health disorders has been shown to be unsatisfactory in several areas. We suggest that clinicians routinely assess and monitor physical health needs of patients with serious mental illness.
authors.affiliation: Department of Liason Psychiatry, Brandon Unit, Leicester General Hospital, Leicester, UK. Alex.mitchell@leicspart.nhs.uk
authors.forename: Alex J
authors.initials: AJ
authors.lastname: Mitchell
authors.forename: Darren
authors.initials: D
authors.lastname: Malone
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight; D002908:Chronic Disease; D015897:Comorbidity; D003920:Diabetes Mellitus / Q000453:epidemiology; D006293:Health Promotion; D006304:Health Status; D006801:Humans; D008403:Mass Screening; D024821:Metabolic Syndrome / Q000453:epidemiology; D012559:Schizophrenia / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology*
chemical_list: D014150:Antipsychotic Agents; D001786:Blood Glucose